Header Logo

Diego Cadavid

Concepts (305)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
22
2020
207
3.800
Why?
Borrelia
11
2011
25
2.690
Why?
Multiple Sclerosis, Chronic Progressive
6
2019
14
2.450
Why?
Relapsing Fever
8
2008
16
1.950
Why?
Optic Neuritis
5
2019
9
1.890
Why?
Brain
12
2013
1493
1.660
Why?
Antibodies, Monoclonal
5
2019
836
1.520
Why?
Muscular Dystrophy, Facioscapulohumeral
5
2024
39
1.510
Why?
Interleukin-10
6
2011
149
1.510
Why?
Disability Evaluation
10
2019
199
1.500
Why?
Borrelia Infections
5
2010
11
1.490
Why?
Borrelia burgdorferi
8
2016
68
1.340
Why?
Multiple Sclerosis, Relapsing-Remitting
5
2019
33
1.270
Why?
Lyme Disease
7
2016
104
1.260
Why?
Lyme Neuroborreliosis
5
2016
9
1.250
Why?
Immunologic Factors
7
2018
103
1.170
Why?
Visual Acuity
3
2019
117
1.120
Why?
Fragile X Syndrome
2
2022
27
0.970
Why?
Disease Progression
8
2022
1119
0.960
Why?
Bacterial Outer Membrane Proteins
3
2010
121
0.960
Why?
Magnetic Resonance Imaging
15
2022
2057
0.940
Why?
Nerve Tissue Proteins
3
2019
418
0.930
Why?
Walking
6
2016
228
0.910
Why?
Chemokine CXCL13
6
2011
8
0.910
Why?
Spirochaetales
3
2010
4
0.760
Why?
Lipoproteins
3
2011
80
0.750
Why?
Membrane Proteins
3
2019
850
0.750
Why?
Endothelium, Vascular
3
2011
169
0.720
Why?
Bacteremia
3
2011
92
0.690
Why?
Female
43
2024
30779
0.640
Why?
Male
41
2024
27794
0.640
Why?
Visually Impaired Persons
1
2019
13
0.640
Why?
Severity of Illness Index
6
2018
1483
0.630
Why?
Antigens, Bacterial
2
2010
200
0.610
Why?
Muscle, Skeletal
5
2022
674
0.600
Why?
Central Nervous System Bacterial Infections
2
2010
3
0.600
Why?
Chemokines, CXC
4
2007
29
0.590
Why?
Humans
54
2024
59479
0.590
Why?
Macaca mulatta
6
2005
228
0.590
Why?
Adult
28
2024
15704
0.580
Why?
Middle Aged
27
2024
16342
0.560
Why?
Recovery of Function
1
2019
271
0.560
Why?
Antibodies, Monoclonal, Humanized
3
2013
217
0.540
Why?
Treatment Outcome
9
2024
5293
0.530
Why?
Gadolinium DTPA
3
2020
85
0.520
Why?
Apoptosis
4
2011
1033
0.520
Why?
B-Lymphocytes
4
2009
550
0.500
Why?
Inflammation
4
2017
1099
0.490
Why?
Benchmarking
1
2016
135
0.490
Why?
Blood-Brain Barrier
6
2017
81
0.480
Why?
Exercise Test
2
2013
242
0.480
Why?
Double-Blind Method
5
2024
713
0.480
Why?
Glatiramer Acetate
5
2016
6
0.470
Why?
Mice
16
2019
10308
0.440
Why?
Animals
23
2019
19677
0.430
Why?
Oligodendroglia
1
2013
33
0.420
Why?
Interferon-beta
5
2013
76
0.420
Why?
Young Adult
10
2019
4277
0.410
Why?
Patient Outcome Assessment
1
2013
52
0.410
Why?
Central Nervous System Diseases
1
2013
56
0.410
Why?
Self Report
1
2015
359
0.400
Why?
Simvastatin
1
2012
27
0.390
Why?
Contrast Media
4
2020
405
0.390
Why?
Interferon beta-1b
4
2016
5
0.380
Why?
Mice, SCID
6
2009
513
0.370
Why?
Encephalitis
1
2012
34
0.370
Why?
Anti-Bacterial Agents
2
2016
737
0.370
Why?
Microcirculation
2
2008
52
0.370
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2012
208
0.340
Why?
Antibodies, Bacterial
6
2008
187
0.340
Why?
Longitudinal Studies
7
2017
1188
0.340
Why?
Spirochaetales Infections
1
2010
1
0.340
Why?
Time Factors
9
2018
3619
0.330
Why?
Adolescent
9
2019
5854
0.320
Why?
Acute Disease
4
2019
660
0.320
Why?
Image Processing, Computer-Assisted
7
2020
651
0.320
Why?
Natalizumab
4
2018
11
0.300
Why?
Neuropsychological Tests
5
2014
372
0.300
Why?
Neurons
2
2013
865
0.290
Why?
Evoked Potentials, Visual
2
2018
13
0.290
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2008
529
0.290
Why?
Reproducibility of Results
7
2022
1561
0.280
Why?
Cognition Disorders
3
2014
215
0.280
Why?
Vestibular Diseases
1
2007
9
0.280
Why?
Myocarditis
2
2005
60
0.270
Why?
Cross-Sectional Studies
3
2022
2383
0.270
Why?
Gadolinium
4
2017
103
0.260
Why?
Surveys and Questionnaires
4
2019
2516
0.260
Why?
Peptides
4
2012
549
0.250
Why?
Root Canal Therapy
2
2017
3
0.250
Why?
Radiography, Dental, Digital
2
2017
3
0.250
Why?
Disease Models, Animal
4
2004
2054
0.240
Why?
Cerebrovascular Circulation
1
2006
175
0.240
Why?
T-Lymphocytes
2
2007
986
0.240
Why?
Cone-Beam Computed Tomography
2
2017
70
0.240
Why?
Cyclopropanes
2
2024
50
0.240
Why?
Borrelia burgdorferi Group
1
2004
27
0.230
Why?
Pyridines
2
2024
98
0.230
Why?
Mice, Knockout
4
2011
1999
0.210
Why?
Leukoencephalopathy, Progressive Multifocal
2
2013
18
0.210
Why?
Heart Diseases
1
2005
206
0.210
Why?
Cytokines
2
2008
912
0.210
Why?
Homeodomain Proteins
2
2020
254
0.210
Why?
Adipose Tissue
2
2022
283
0.200
Why?
Spinal Cord
1
2004
194
0.200
Why?
Hair Follicle
1
2022
29
0.200
Why?
Serotyping
3
2007
50
0.200
Why?
Polymerase Chain Reaction
3
2009
496
0.200
Why?
Fragile X Mental Retardation Protein
1
2022
38
0.200
Why?
Social Communication Disorder
1
2022
2
0.190
Why?
Quality of Life
4
2019
1138
0.190
Why?
Placebos
2
2012
68
0.190
Why?
Cerebral Cortex
2
2017
250
0.180
Why?
Inflammation Mediators
1
2002
171
0.180
Why?
RNA, Messenger
2
2022
1469
0.180
Why?
Cerebellar Nuclei
1
2020
4
0.180
Why?
Phenotype
1
2004
1139
0.170
Why?
Gray Matter
1
2020
31
0.170
Why?
Cluster Analysis
2
2012
245
0.170
Why?
Tooth Root
2
2017
2
0.170
Why?
Chemokines
2
2013
93
0.170
Why?
Immunocompromised Host
3
2006
101
0.170
Why?
Bites and Stings
3
2004
11
0.170
Why?
Electroencephalography
2
2019
135
0.170
Why?
p38 Mitogen-Activated Protein Kinases
1
2020
127
0.160
Why?
White Matter
2
2019
114
0.160
Why?
Evoked Potentials, Somatosensory
1
2019
8
0.160
Why?
Evoked Potentials, Auditory
1
2019
10
0.160
Why?
DNA Primers
2
2010
289
0.160
Why?
Myocardium
3
2006
264
0.160
Why?
Retrospective Studies
6
2020
6088
0.160
Why?
Ixodes
3
2004
31
0.160
Why?
Pilot Projects
1
2022
916
0.160
Why?
Statistics, Nonparametric
2
2012
209
0.160
Why?
Sickness Impact Profile
1
2019
46
0.160
Why?
Encephalomyelitis, Autoimmune, Experimental
1
2019
56
0.160
Why?
Infusions, Intravenous
1
2019
163
0.150
Why?
Optic Nerve
1
2018
25
0.150
Why?
Clinical Trials as Topic
2
2013
439
0.150
Why?
Retinal Ganglion Cells
1
2018
27
0.150
Why?
Biomarkers
2
2022
1306
0.150
Why?
Secondary Prevention
1
2019
153
0.150
Why?
Immunosuppressive Agents
2
2012
365
0.150
Why?
Autism Spectrum Disorder
1
2022
175
0.150
Why?
Mice, Inbred C57BL
4
2019
3240
0.150
Why?
Antibodies
2
2009
179
0.150
Why?
Hand
1
2018
69
0.140
Why?
PubMed
1
2017
10
0.140
Why?
Penicillin G
1
2016
5
0.140
Why?
Cefotaxime
1
2016
4
0.140
Why?
Amoxicillin
1
2016
7
0.140
Why?
Ceftriaxone
1
2016
19
0.130
Why?
Doxycycline
1
2016
42
0.130
Why?
International Cooperation
1
2017
84
0.130
Why?
Enzyme-Linked Immunosorbent Assay
2
2008
446
0.130
Why?
Predictive Value of Tests
3
2013
1029
0.130
Why?
Tomography, Optical Coherence
1
2018
214
0.130
Why?
Mice, Inbred BALB C
2
2009
868
0.130
Why?
Upper Extremity
1
2016
50
0.130
Why?
Myocytes, Cardiac
2
2006
88
0.120
Why?
Hypophosphatemia
1
2015
6
0.120
Why?
Psychometrics
2
2014
362
0.120
Why?
Activities of Daily Living
2
2014
288
0.120
Why?
DNA, Bacterial
2
2006
260
0.120
Why?
Demography
1
2015
169
0.120
Why?
Endothelial Growth Factors
1
2014
20
0.110
Why?
Brain Injuries
1
2016
135
0.110
Why?
Synovial Membrane
1
2014
19
0.110
Why?
Aged
6
2022
13426
0.110
Why?
RNA, Bacterial
2
2004
68
0.110
Why?
Immunohistochemistry
3
2005
851
0.110
Why?
Disabled Persons
1
2016
189
0.110
Why?
Gait Disorders, Neurologic
1
2013
17
0.110
Why?
Oligonucleotide Array Sequence Analysis
2
2007
295
0.110
Why?
Heart
2
2007
274
0.110
Why?
Autoantibodies
1
2014
172
0.110
Why?
Radiography, Bitewing
1
2013
1
0.110
Why?
Dental Pulp Cavity
1
2013
2
0.110
Why?
Interferon beta-1a
1
2013
9
0.100
Why?
Randomized Controlled Trials as Topic
1
2016
678
0.100
Why?
Dexamethasone
2
2004
201
0.100
Why?
Employment
1
2013
124
0.100
Why?
Neuroimaging
1
2013
144
0.100
Why?
Follow-Up Studies
3
2013
2341
0.100
Why?
Anti-Inflammatory Agents
2
2004
164
0.100
Why?
Cell Survival
1
2013
558
0.090
Why?
Cell Line
3
2020
1984
0.090
Why?
Remission Induction
1
2011
137
0.090
Why?
fas Receptor
1
2011
55
0.090
Why?
Caspase 3
1
2011
103
0.090
Why?
Drug Administration Schedule
2
2015
284
0.090
Why?
Mice, Inbred Strains
1
2010
180
0.080
Why?
Drug Tolerance
1
2009
29
0.080
Why?
Neurologic Examination
1
2009
52
0.080
Why?
Molecular Conformation
1
2009
133
0.080
Why?
Diffusion Magnetic Resonance Imaging
1
2010
145
0.080
Why?
Observer Variation
1
2009
205
0.080
Why?
Tissue Distribution
1
2009
288
0.080
Why?
Prospective Studies
2
2013
3072
0.080
Why?
In Situ Nick-End Labeling
1
2008
43
0.080
Why?
Structure-Activity Relationship
1
2009
365
0.080
Why?
Phylogeny
1
2009
337
0.080
Why?
Coloring Agents
1
2008
53
0.070
Why?
Cognition
1
2012
455
0.070
Why?
Base Sequence
1
2010
1302
0.070
Why?
Interferon Type I
1
2009
169
0.070
Why?
Aging
1
2013
710
0.070
Why?
Sensitivity and Specificity
1
2010
1097
0.070
Why?
Recombinant Proteins
1
2009
691
0.070
Why?
Killer Cells, Natural
1
2008
218
0.070
Why?
Spleen
1
2008
480
0.070
Why?
Interleukin-6
1
2008
309
0.070
Why?
Arthritis
1
2007
49
0.070
Why?
Hemorrhage
1
2008
259
0.070
Why?
Primates
1
2006
42
0.070
Why?
Immunoglobulins
1
2006
76
0.070
Why?
Antibody Formation
1
2006
108
0.070
Why?
Complement Activation
1
2006
49
0.060
Why?
Interferon-gamma
1
2008
551
0.060
Why?
Cells, Cultured
1
2010
2095
0.060
Why?
Survival Rate
1
2008
801
0.060
Why?
Gene Expression Regulation, Bacterial
1
2007
151
0.060
Why?
Down-Regulation
1
2007
307
0.060
Why?
Tumor Necrosis Factor-alpha
1
2008
587
0.060
Why?
Caspases
1
2006
166
0.060
Why?
Germinal Center
1
2005
38
0.060
Why?
Nervous System
1
2005
69
0.060
Why?
Brain Infarction
1
2004
19
0.060
Why?
Safety
1
2005
141
0.060
Why?
Mice, Inbred C3H
1
2004
173
0.060
Why?
Complement C1q
1
2004
8
0.060
Why?
Leukocytes, Mononuclear
1
2005
238
0.060
Why?
Fluorescent Antibody Technique, Indirect
1
2004
34
0.060
Why?
Immunoenzyme Techniques
1
2004
107
0.050
Why?
Adjuvants, Immunologic
1
2005
224
0.050
Why?
Aorta
1
2004
108
0.050
Why?
Needles
1
2003
65
0.050
Why?
Signal Transduction
1
2013
2901
0.050
Why?
HIV Infections
1
2010
914
0.050
Why?
Genotype
1
2004
619
0.050
Why?
DNA-Binding Proteins
1
2008
1151
0.050
Why?
Multicenter Studies as Topic
1
2022
130
0.050
Why?
Research Design
2
2018
556
0.050
Why?
Child
3
2022
4205
0.050
Why?
Area Under Curve
1
2021
141
0.040
Why?
Macrophages
1
2006
1015
0.040
Why?
Immunity, Innate
1
2007
773
0.040
Why?
Muscle Cells
1
2020
26
0.040
Why?
Feasibility Studies
1
2022
526
0.040
Why?
Administration, Oral
1
2021
353
0.040
Why?
Cohort Studies
2
2017
2377
0.040
Why?
Linear Models
1
2020
403
0.040
Why?
Myelin Sheath
1
2019
34
0.040
Why?
Chronic Disease
1
2002
717
0.040
Why?
Gene Expression Profiling
1
2002
720
0.040
Why?
Cell Death
1
2020
271
0.040
Why?
Nerve Fibers
1
2018
29
0.040
Why?
Visual Perception
1
2018
41
0.040
Why?
Visual Fields
1
2018
43
0.040
Why?
Photic Stimulation
1
2018
89
0.040
Why?
Software
1
2020
366
0.030
Why?
Communication
1
2022
547
0.030
Why?
Child, Preschool
1
2022
1796
0.030
Why?
Image Enhancement
1
2017
188
0.030
Why?
World Health Organization
1
2014
30
0.030
Why?
Phosphates
1
2015
90
0.030
Why?
Imaging, Three-Dimensional
1
2016
277
0.030
Why?
Prognosis
1
2018
1598
0.030
Why?
Space Perception
1
2014
19
0.030
Why?
Acoustic Stimulation
1
2014
50
0.030
Why?
Treatment Failure
1
2014
186
0.030
Why?
Demyelinating Diseases
1
2013
16
0.030
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
15
0.030
Why?
Calcium Sulfate
1
2013
1
0.030
Why?
Dental Restoration, Temporary
1
2013
1
0.030
Why?
Periapical Diseases
1
2013
1
0.030
Why?
Root Canal Irrigants
1
2013
1
0.030
Why?
Root Canal Obturation
1
2013
1
0.030
Why?
Zinc Oxide-Eugenol Cement
1
2013
1
0.030
Why?
Rubber Dams
1
2013
1
0.030
Why?
Root Canal Preparation
1
2013
1
0.030
Why?
Zinc Sulfate
1
2013
1
0.030
Why?
Root Canal Filling Materials
1
2013
2
0.030
Why?
Dental Restoration, Permanent
1
2013
2
0.030
Why?
Methylmethacrylates
1
2013
2
0.030
Why?
Anatomic Variation
1
2013
6
0.030
Why?
Sodium Hypochlorite
1
2013
12
0.030
Why?
Gene Expression Regulation
1
2020
1554
0.030
Why?
Early Diagnosis
1
2013
91
0.030
Why?
Mobility Limitation
1
2013
47
0.030
Why?
Dose-Response Relationship, Drug
1
2015
805
0.030
Why?
Statistics as Topic
1
2013
146
0.030
Why?
Memory
1
2014
111
0.030
Why?
Product Surveillance, Postmarketing
1
2012
20
0.030
Why?
Microscopy
1
2013
91
0.020
Why?
New York
1
2012
134
0.020
Why?
Diagnosis, Differential
1
2013
934
0.020
Why?
Analysis of Variance
1
2012
591
0.020
Why?
Single-Blind Method
1
2009
136
0.020
Why?
Monitoring, Physiologic
1
2009
149
0.020
Why?
Necrosis
1
2004
140
0.010
Why?
Flow Cytometry
1
2005
645
0.010
Why?
Immunoglobulin G
1
2005
446
0.010
Why?
Aged, 80 and over
1
2004
5128
0.010
Why?
Risk Factors
1
2004
4991
0.010
Why?
Cadavid's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (305)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_